The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cancer Supportive Care Market Research Report 2024
Synopsis
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life.
The global Cancer Supportive Care market was valued at US$ 22140 million in 2023 and is anticipated to reach US$ 24750 million by 2030, witnessing a CAGR of 1.6% during the forecast period 2024-2030.
With growing prevalence of cancer, the demand for cancer treatments, such as chemotherapy has also been consistently on the rise since the past decade. However, radiation therapy brings with it a host of side effects that are challenging for cancer patients to face while they undergo the course of treatment. While the cancer treatment realm is tremendously progressing, the incidences of side effects are increasing as well, which are addressed by cancer supportive care. The advent of technology in cancer supportive care has enabled to treat different signs and symptoms following the chemotherapy procedure, in addition to chemotherapy-induced vomiting, nausea, neutropenia, and anemia. The global market for cancer supportive care products is currently thriving at a sound pace and is anticipated to see steady growth over the next few years.
This report aims to provide a comprehensive presentation of the global market for Cancer Supportive Care, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Supportive Care.
Report Scope
The Cancer Supportive Care market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Supportive Care market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Supportive Care manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Helsinn Healthcare
Johnson &Johnson
Merck
F. Hoffmann-La Roche
GlaxoSmithKline
Novartis
TESARO
Teva Pharmaceutical Industries
Segment by Type
Nonsteroidal Erythropoietin Stimulating Agents
Opioid Analgesics
Anti-Imflammatory Drugs
Anti-Infective Drugs
Bisphosphonates
Anti-Emetics Drugs
Monoclonal Antibodies
Granulocyte Colony Stimulating Factor
Segment by Application
Lung Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Bladder Cancer
Leukemia
Ovarian Cancer
Melanoma
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cancer Supportive Care manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cancer Supportive Care in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life.
The global Cancer Supportive Care market was valued at US$ 22140 million in 2023 and is anticipated to reach US$ 24750 million by 2030, witnessing a CAGR of 1.6% during the forecast period 2024-2030.
With growing prevalence of cancer, the demand for cancer treatments, such as chemotherapy has also been consistently on the rise since the past decade. However, radiation therapy brings with it a host of side effects that are challenging for cancer patients to face while they undergo the course of treatment. While the cancer treatment realm is tremendously progressing, the incidences of side effects are increasing as well, which are addressed by cancer supportive care. The advent of technology in cancer supportive care has enabled to treat different signs and symptoms following the chemotherapy procedure, in addition to chemotherapy-induced vomiting, nausea, neutropenia, and anemia. The global market for cancer supportive care products is currently thriving at a sound pace and is anticipated to see steady growth over the next few years.
This report aims to provide a comprehensive presentation of the global market for Cancer Supportive Care, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Supportive Care.
Report Scope
The Cancer Supportive Care market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Supportive Care market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Supportive Care manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Helsinn Healthcare
Johnson &Johnson
Merck
F. Hoffmann-La Roche
GlaxoSmithKline
Novartis
TESARO
Teva Pharmaceutical Industries
Segment by Type
Nonsteroidal Erythropoietin Stimulating Agents
Opioid Analgesics
Anti-Imflammatory Drugs
Anti-Infective Drugs
Bisphosphonates
Anti-Emetics Drugs
Monoclonal Antibodies
Granulocyte Colony Stimulating Factor
Segment by Application
Lung Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Bladder Cancer
Leukemia
Ovarian Cancer
Melanoma
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cancer Supportive Care manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cancer Supportive Care in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Cancer Supportive Care Market Overview
1.1 Product Overview and Scope of Cancer Supportive Care
1.2 Cancer Supportive Care Segment by Type
1.2.1 Global Cancer Supportive Care Market Value Comparison by Type (2024-2030)
1.2.2 Nonsteroidal Erythropoietin Stimulating Agents
1.2.3 Opioid Analgesics
1.2.4 Anti-Imflammatory Drugs
1.2.5 Anti-Infective Drugs
1.2.6 Bisphosphonates
1.2.7 Anti-Emetics Drugs
1.2.8 Monoclonal Antibodies
1.2.9 Granulocyte Colony Stimulating Factor
1.3 Cancer Supportive Care Segment by Application
1.3.1 Global Cancer Supportive Care Market Value by Application: (2024-2030)
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Prostate Cancer
1.3.5 Liver Cancer
1.3.6 Bladder Cancer
1.3.7 Leukemia
1.3.8 Ovarian Cancer
1.3.9 Melanoma
1.3.10 Others
1.4 Global Cancer Supportive Care Market Size Estimates and Forecasts
1.4.1 Global Cancer Supportive Care Revenue 2019-2030
1.4.2 Global Cancer Supportive Care Sales 2019-2030
1.4.3 Global Cancer Supportive Care Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cancer Supportive Care Market Competition by Manufacturers
2.1 Global Cancer Supportive Care Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cancer Supportive Care Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cancer Supportive Care Average Price by Manufacturers (2019-2024)
2.4 Global Cancer Supportive Care Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cancer Supportive Care, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cancer Supportive Care, Product Type & Application
2.7 Cancer Supportive Care Market Competitive Situation and Trends
2.7.1 Cancer Supportive Care Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cancer Supportive Care Players Market Share by Revenue
2.7.3 Global Cancer Supportive Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cancer Supportive Care Retrospective Market Scenario by Region
3.1 Global Cancer Supportive Care Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cancer Supportive Care Global Cancer Supportive Care Sales by Region: 2019-2030
3.2.1 Global Cancer Supportive Care Sales by Region: 2019-2024
3.2.2 Global Cancer Supportive Care Sales by Region: 2025-2030
3.3 Global Cancer Supportive Care Global Cancer Supportive Care Revenue by Region: 2019-2030
3.3.1 Global Cancer Supportive Care Revenue by Region: 2019-2024
3.3.2 Global Cancer Supportive Care Revenue by Region: 2025-2030
3.4 North America Cancer Supportive Care Market Facts & Figures by Country
3.4.1 North America Cancer Supportive Care Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cancer Supportive Care Sales by Country (2019-2030)
3.4.3 North America Cancer Supportive Care Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cancer Supportive Care Market Facts & Figures by Country
3.5.1 Europe Cancer Supportive Care Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cancer Supportive Care Sales by Country (2019-2030)
3.5.3 Europe Cancer Supportive Care Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cancer Supportive Care Market Facts & Figures by Country
3.6.1 Asia Pacific Cancer Supportive Care Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cancer Supportive Care Sales by Country (2019-2030)
3.6.3 Asia Pacific Cancer Supportive Care Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cancer Supportive Care Market Facts & Figures by Country
3.7.1 Latin America Cancer Supportive Care Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cancer Supportive Care Sales by Country (2019-2030)
3.7.3 Latin America Cancer Supportive Care Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cancer Supportive Care Market Facts & Figures by Country
3.8.1 Middle East and Africa Cancer Supportive Care Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cancer Supportive Care Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cancer Supportive Care Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cancer Supportive Care Sales by Type (2019-2030)
4.1.1 Global Cancer Supportive Care Sales by Type (2019-2024)
4.1.2 Global Cancer Supportive Care Sales by Type (2025-2030)
4.1.3 Global Cancer Supportive Care Sales Market Share by Type (2019-2030)
4.2 Global Cancer Supportive Care Revenue by Type (2019-2030)
4.2.1 Global Cancer Supportive Care Revenue by Type (2019-2024)
4.2.2 Global Cancer Supportive Care Revenue by Type (2025-2030)
4.2.3 Global Cancer Supportive Care Revenue Market Share by Type (2019-2030)
4.3 Global Cancer Supportive Care Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cancer Supportive Care Sales by Application (2019-2030)
5.1.1 Global Cancer Supportive Care Sales by Application (2019-2024)
5.1.2 Global Cancer Supportive Care Sales by Application (2025-2030)
5.1.3 Global Cancer Supportive Care Sales Market Share by Application (2019-2030)
5.2 Global Cancer Supportive Care Revenue by Application (2019-2030)
5.2.1 Global Cancer Supportive Care Revenue by Application (2019-2024)
5.2.2 Global Cancer Supportive Care Revenue by Application (2025-2030)
5.2.3 Global Cancer Supportive Care Revenue Market Share by Application (2019-2030)
5.3 Global Cancer Supportive Care Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Cancer Supportive Care Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amgen Cancer Supportive Care Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Helsinn Healthcare
6.2.1 Helsinn Healthcare Corporation Information
6.2.2 Helsinn Healthcare Description and Business Overview
6.2.3 Helsinn Healthcare Cancer Supportive Care Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Helsinn Healthcare Cancer Supportive Care Product Portfolio
6.2.5 Helsinn Healthcare Recent Developments/Updates
6.3 Johnson &Johnson
6.3.1 Johnson &Johnson Corporation Information
6.3.2 Johnson &Johnson Description and Business Overview
6.3.3 Johnson &Johnson Cancer Supportive Care Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson &Johnson Cancer Supportive Care Product Portfolio
6.3.5 Johnson &Johnson Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Cancer Supportive Care Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Cancer Supportive Care Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 F. Hoffmann-La Roche
6.5.1 F. Hoffmann-La Roche Corporation Information
6.5.2 F. Hoffmann-La Roche Description and Business Overview
6.5.3 F. Hoffmann-La Roche Cancer Supportive Care Sales, Revenue and Gross Margin (2019-2024)
6.5.4 F. Hoffmann-La Roche Cancer Supportive Care Product Portfolio
6.5.5 F. Hoffmann-La Roche Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Cancer Supportive Care Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GlaxoSmithKline Cancer Supportive Care Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Cancer Supportive Care Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Cancer Supportive Care Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 TESARO
6.8.1 TESARO Corporation Information
6.8.2 TESARO Description and Business Overview
6.8.3 TESARO Cancer Supportive Care Sales, Revenue and Gross Margin (2019-2024)
6.8.4 TESARO Cancer Supportive Care Product Portfolio
6.8.5 TESARO Recent Developments/Updates
6.9 Teva Pharmaceutical Industries
6.9.1 Teva Pharmaceutical Industries Corporation Information
6.9.2 Teva Pharmaceutical Industries Description and Business Overview
6.9.3 Teva Pharmaceutical Industries Cancer Supportive Care Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Teva Pharmaceutical Industries Cancer Supportive Care Product Portfolio
6.9.5 Teva Pharmaceutical Industries Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cancer Supportive Care Industry Chain Analysis
7.2 Cancer Supportive Care Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cancer Supportive Care Production Mode & Process
7.4 Cancer Supportive Care Sales and Marketing
7.4.1 Cancer Supportive Care Sales Channels
7.4.2 Cancer Supportive Care Distributors
7.5 Cancer Supportive Care Customers
8 Cancer Supportive Care Market Dynamics
8.1 Cancer Supportive Care Industry Trends
8.2 Cancer Supportive Care Market Drivers
8.3 Cancer Supportive Care Market Challenges
8.4 Cancer Supportive Care Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
